ANTISENSE MODULATION OF MHC CLASS II TRANSACTIVATOR EXPRESSION

Details for Australian Patent Application No. 2002346632 (hide)

Owner ISIS PHARMACEUTICALS, INC.

Inventors BENNETT, Frank, C.; DOBIE, Kenneth, W.

Pub. Number AU-A-2002346632

PCT Number PCT/US02/38616

PCT Pub. Number WO2003/050247

Priority 10/006,366 05.12.01 US

Filing date 4 December 2002

Wipo publication date 23 June 2003

Event Publications

13 March 2003 Complete Application Filed

  Priority application(s): 10/006,366 05.12.01 US

28 August 2003 Application Open to Public Inspection

  Published as AU-A-2002346632

19 August 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002346633-PLL BANDWIDTH SWITCHING

2002346631-ANTISENSE MODULATION OF PHOSPHATIDYLINOSITOL4-PHOSPHATE 5-KINASE, IAlpha EXPRESSION